SE STRAUS, HA SMITH, C BRICKMAN, P … - Annals of Internal Medicine, 1982 - Am Coll Physicians Over 25 episodes of severe chronic and recurrent mucocutaneous herpes simplex
virus infections in five immunodeficient patients were successfully treated with
intravenous or oral acyclovir treatment. Acyclovir was shown to inhibit ... Cited by 80 - Related articles - All 2 versions
JC WADE, B NEWTON, C McLAREN, N … - Annals of Internal Medicine, 1982 - Am Coll Physicians Acyclovir, a new antiviral agent, was compared to a placebo in a randomized
double-blind trial of treatment for culture-proven herpes simplex virus
infection after marrow transplantation. Patients received either ... Cited by 187 - Related articles - All 2 versions
CD Mitchell, B Bean, SR Gentry, KE Groth, JR … - Lancet, 1981 - ncbi.nlm.nih.gov 11 of 24 immunocompromised patients with mucocutaneous herpes simplex virus
(HSV) infections were given intravenous acyclovir in a randomised double-blind
placebo-controlled study. Patients receiving acyclovir experienced no major ... Cited by 118 - Related articles - All 3 versions
S Chou, JG Gallagher, TC Merigan - The Lancet, 1981 - Elsevier Viral Cultures of mucocutaneous herpes simplex lesions became negative in 5
heart-transplant patients given a 7-day course of intravenous acyclovir. Relief
of pain and healing of lesions paralleled the virological response. Similar ... Cited by 48 - Related articles - All 3 versions
DH SHEPP, BA NEWTON, PS DANDLIKER, … - Annals of internal medicine, 1985 - Am Coll Physicians In a randomized, double-blinded, placebo-controlled trial, we compared the
therapeutic effect of oral acyclovir (400 mg five times daily for 10 days) with
that of placebo in patients with marrow transplants and culture-proven ... Cited by 81 - Related articles - All 3 versions
RJ Whitley, M Levin, N Barton, BJ Hershey, G … - The Journal of infectious diseases, 1984 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES . VOL. 150, NO. 3 . SEPTEMBER 1984 (c) 1984
by The University of Chicago. All rights reserved. 0022-1899/84/5003-0002$01.00 ... Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Cited by 70 - Related articles - All 3 versions
SE STRAUS, M SEIDLIN, H TAKIFF, D … - Annals of internal medicine, 1984 - Am Coll Physicians Thirty-two episodes of herpes simplex virus infection in four immunodeficient
patients with frequent recurrences were successfully treated with oral
acyclovir, one capsule five times a day for 5 days. In 23 of these ... Cited by 75 - Related articles - All 3 versions
RJ Whitley, S Spruance, FG Hayden, J Overall … - The Journal of infectious diseases, 1984 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES * VOL. 149, NO. 1 * JANUARY 1984 ... @ 1984
by The University of Chicago. All rights reserved. 0022-1899/84/4901-0001$00.81 ... Vidarabine Therapy for Mucocutaneous Herpes Simplex Virus Infections Cited by 18 - Related articles - All 3 versions
HH BALFOUR JR - Annals of Internal Medicine, 1983 - Am Coll Physicians Clinical trials have shown that intravenous acyclovir is effective for
prophylaxis and treatment of mucocutaneous herpes simplex virus infections in
immunocompromised patients (1-3) and for treatment of primary genital ... Cited by 51 - Related articles - All 2 versions
AP Fiddian, AM Halsos, BR Kinge, AE Nilsen, … - The American journal of medicine, 1982 - ncbi.nlm.nih.gov Ninety patients with genital herpes (29 initial and 61 recurrent episodes) were
entered into a double-blind randomized trial of oral acyclovir and placebo.
Treatment consisted of 200 mg acyclovir five times a day for five days or ... Cited by 14 - Related articles
